Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Endometrial Neoplasms and CYP1A2[original query] |
---|
Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Feb 14 (2): 357-66. Doherty Jennifer A, Weiss Noel S, Freeman Robert J, Dightman Douglas A, Thornton Perry J, Houck John R, Voigt Lynda F, Rossing Mary Anne, Schwartz Stephen M, Chen C |
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. Journal of the National Cancer Institute 2006 Sep 98 (18): 1311-20. Rebbeck Timothy R, Troxel Andrea B, Wang Yiting, Walker Amy H, Panossian Saarene, Gallagher Stephen, Shatalova Ekaterina G, Blanchard Rebecca, Bunin Greta, DeMichele Angela, Rubin Stephen C, Baumgarten Mona, Berlin Michelle, Schinnar Rita, Berlin Jesse A, Strom Brian |
Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk. The pharmacogenomics journal 0 6 (3): 189-93. Mikhailova O N, Gulyaeva L F, Prudnikov A V, Gerasimov A V, Krasilnikov S |
CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer 2008 May 112 (9): 1964-73. Hirata Hiroshi, Hinoda Yuji, Okayama Naoko, Suehiro Yutaka, Kawamoto Ken, Kikuno Nobuyuki, Rabban Joseph T, Chen Lee May, Dahiya Rajv |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: